Accelerating the discovery of new chemical probes for drug development
Administrative Supplement to: Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches
This study is working on a new way to find special tools that can help target proteins linked to different diseases, using smart technology to speed up the process, which could lead to quicker and better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11037516 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to quickly identify and create chemical probes that can specifically target proteins involved in various diseases. By integrating advanced artificial intelligence with crystallographic data, the project aims to predict how small molecules can bind to these proteins effectively. The approach involves screening millions of compounds and validating their effectiveness in the lab, ultimately leading to the creation of new tools for drug discovery. Patients may benefit from the faster development of targeted therapies that could arise from these discoveries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve protein targets for which new chemical probes are being developed.
Not a fit: Patients with conditions that do not involve the specific protein targets being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the rapid development of new drugs that are more effective and targeted for various diseases.
How similar studies have performed: Other research initiatives have shown promise in using AI and crystallographic data for drug discovery, indicating a potential for success in this novel approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Tropsha, Alexander — Univ of North Carolina Chapel Hill
- Study coordinator: Tropsha, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.